Nature Communications (Jan 2019)

Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response

  • Yael Haberman,
  • Rebekah Karns,
  • Phillip J. Dexheimer,
  • Melanie Schirmer,
  • Judith Somekh,
  • Ingrid Jurickova,
  • Tzipi Braun,
  • Elizabeth Novak,
  • Laura Bauman,
  • Margaret H. Collins,
  • Angela Mo,
  • Michael J. Rosen,
  • Erin Bonkowski,
  • Nathan Gotman,
  • Alison Marquis,
  • Mason Nistel,
  • Paul A. Rufo,
  • Susan S. Baker,
  • Cary G. Sauer,
  • James Markowitz,
  • Marian D. Pfefferkorn,
  • Joel R. Rosh,
  • Brendan M. Boyle,
  • David R. Mack,
  • Robert N. Baldassano,
  • Sapana Shah,
  • Neal S. Leleiko,
  • Melvin B. Heyman,
  • Anne M. Grifiths,
  • Ashish S. Patel,
  • Joshua D. Noe,
  • Bruce J. Aronow,
  • Subra Kugathasan,
  • Thomas D. Walters,
  • Greg Gibson,
  • Sonia Davis Thomas,
  • Kevin Mollen,
  • Shai Shen-Orr,
  • Curtis Huttenhower,
  • Ramnik J. Xavier,
  • Jeffrey S. Hyams,
  • Lee A. Denson

DOI
https://doi.org/10.1038/s41467-018-07841-3
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 13

Abstract

Read online

The severity of ulcerative colitis, and response to treatment, is highly variable. Here, the authors examine rectal gene expression signatures and faecal microbiomes of children and adults with the disease and provide new insights in to pathogenesis.